This ASX healthcare stock is up 70% in a year and climbing again today
After already delivering a standout 12-month run, Cogstate Ltd (ASX: CGS) shares are back in the green on Wednesday. The…
Cartography Biosciences Advances Strategic Oncology Collaboration with Gilead’s First Option Target Exercise
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cartography Biosciences, Inc., a clinical-stage biotechnology company advancing a differentiated pipeline of antibody-based cancer…
Why this ASX healthcare stock is surging while the market sinks on Middle East fears
The Avita Medical Inc (ASX: AVH) share price is pushing higher again on Friday, extending its strong short-term rebound. In…
Health-care workers risk their lives in warzones. Are we protecting them enough?
Warzones are full of danger. But that’s never stopped humanitarian workers from living and working in such places,…
Cannabis legalization spurs innovation, but not always in ways that benefit patients or public health
Innovation in health care saves lives. But not all health innovations have enough evidence to actually benefit patients.…
Fresh warning about using superannuation on health treatments after 100 complaints to regulator
A GP found to have engaged in professional misconduct while helping a patient access almost $20,000 of her…
9 Best Healthcare Penny Stocks to Buy According to Hedge Funds
In this article, we look at the 9 Best Healthcare Penny Stocks to Buy According to Hedge Funds.…
Inside the £64bn pharma deal that could cost more lives than…
Nick Dearden of the nonprofit Global Justice Now said: “When it comes to a piece of domestic policy…
Hospitals launch chatbots, creating another funnel for patient intake
Katie Palmer covers telehealth, clinical artificial intelligence, and the health data economy — with an emphasis on the…
6 Health Issues Eye Doctors Can Spot At Your Appointment
Unfortunately, many diseases aren’t always straightforward and simple like we want them to be. For starters, certain health…
Mitrix moves mitochondria into the clinic
Early human safety data and new US clinics signal a shift from theory to real-world testing for mitochondrial…
Eli Lilly Just Launched Its $149 Obesity Pill – Eli Lilly (NYSE:LLY)
Eli Lilly and Co. (NYSE:LLY) on Wednesday announced that Foundayo (orforglipron) is now available to adults with obesity…